By Geoffrey Smith
Investing.com — U.S. stock markets opened at new record highs for a second straight day on Tuesday, as hopes for a boost to the already-agreed fiscal stimulus package dovetailed with the urge to do some “window-dressing” of year-end balance sheets.
By 9: 35 AM ET (1435 GMT), the was up 131 points, or 0.4% at 30,535 points. The and the were also both up 0.4%. All three had posted their highest ever closes already on Monday, supported by confidence that the stimulus package would put a floor under household spending – the biggest part of the U.S. economy – for the next few months.
Among the conspicuous early movers were AstraZeneca (NASDAQ:) ADRs, which rose 1.9% as various reports suggested that U.K. health regulators could approve its Covid-19 vaccine for use as early as today.
Approval from any advanced economy is likely to accelerate the rollout of a vaccine that is substantially cheaper than many of its rivals, even though there are doubts that it is as effective as the drugs developed by Pfizer (NYSE:) and Moderna , which were approved earlier in the month.
Moderna (NASDAQ:) stock, which has been under pressure for most of the time since its drug was approved for emergency use by U.S. regulators, fell another 9.7% in early trading.
Elsewhere, Fiat Chrysler (NYSE:) stock ground out a new 52-week high, although it wasn’t obvious that the announcement of a new $2.5 billion investment in Poland to build electric and hybrid vehicles was responsible for the move.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.